Gastrointestinal Neoplasms
133
18
27
50
Key Insights
Highlights
Success Rate
79% trial completion
Published Results
13 trials with published results (10%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.8%
13 terminated out of 133 trials
79.4%
-7.2% vs benchmark
10%
13 trials in Phase 3/4
26%
13 of 50 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 50 completed trials
Clinical Trials (133)
A Disposable Endoscopic Closing Device Used for the Closure of Gastrointestinal Tissue
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
A Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
Digitally Supported Prehabilitation Before Major Visceral Cancer Surgery
Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC
The Canopy Cancer Collective Clinical Registry Protocol
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors
ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial
Impact of Oral Versus Intravenous 5-FU-Based Adjuvant Regimens on Sleep Quality and Depression in Patients With Gastrointestinal Cancers
Monopolar Current Cutting Knife vs Bipolar RFA Knife
Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
Avatrombopag vs. Placebo for CIT in GI Malignancies
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes